Printer Friendly

Call for Innovative Ideas to Advance Prevention, Treatment, and Cure of Type 1 Diabetes.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), leads a Special Statutory Funding Program ($150 million/year) for Type 1 Diabetes Research, on behalf of the Secretary of the Department of Health and Human Services.

The deadline for submitting proposals is Friday, October 22. Send end of article for details.

The special program supports research to pursue compelling opportunities in type 1 diabetes research (more information on the program can be found at:

The program is framed around six broad, scientific goals:

*I: Identify the Genetic and Environmental Causes of Type 1 Diabetes

*II: Prevent or Reverse Type 1 Diabetes

*III: Develop Cell Replacement Therapy

*IV: Prevent or Reduce Hypoglycemia

*V: Prevent or Reduce the Complications of Type 1 Diabetes

*Goal VI: Attract New Talent and Apply New Technologies to Research on Type 1 Diabetes

The NIDDK invites submission of innovative ideas and approaches toward accelerating progress and overcoming research barriers to the prevention, treatment and cure of type 1 diabetes and its complications.

There is significant flexibility in the use of these funds; opportunities could be pursued through solicitations for traditional research grants or through mechanisms to support larger collaborative efforts. Suggestions should focus on identifying the opportunity and approaches, technology and expertise useful for its development rather than on a funding instrument or solicitation design. Suggestions that will involve creative scientists and scientific communities not currently working on type 1 diabetes, and with the potential to contribute to prevention, treatment and cure of type 1 diabetes, are particularly encouraged.

Use of Submissions: Submissions will be considered by NIH and CDC scientists and by an advisory panel to be convened by NIDDK as part of the process guiding use of the Special Statutory Funding Program for Type 1 Diabetes Research. Therefore, submissions will not be confidential, although they may be anonymous. New research solicitations and/or program enhancements may be developed to address ideas submitted; however, there is no funding associated with this announcement.

Submitting an idea: Please describe your suggested opportunity or approach including:

(1) how it could potentially have a major, positive impact on one or more of the six goals above, and/or (2) the current research barriers it could help overcome. You are welcome to submit more than one idea, but please limit the description of each to one page in length.

For hard-copy submission, please mail or FAX your submission(s) to: Topics Regarding Type 1 Diabetes Research Opportunities, NIH/NIDDK/OSPPA, 9000 Rockville Pike, Building 31, Room 9A05, Bethesda, MD 20892-2560, Attn.: Mary C. Hanlon, Ph.D -- Phone: 301-496-6623, FAX: 301-480-6741

For electronic submissions, please visit the following website:
COPYRIGHT 2004 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Transplant News
Date:Oct 15, 2004
Previous Article:Islet cell transplant's "perfect storm" results in new legislation, CMS reg, $75 million in research funding.
Next Article:Colorado coroner's charge organs were taken before brain death declared refuted by independent panel.

Related Articles
NCRR launches $10.4 million initiative to create islet cell resource centers.
Institutions partner to provide diabetic kidney disease gene studies resources.
New diabetes center opens at Parkland.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters